Featured Post

New consensus guidance for beta-lactam dose individualization

Read More
  1. Home
  2. Resources
  3. Blog
Product Innovation Sep 24, 2026

Continuous learning in practice: three ways to improve adult vancomycin models, and a better way to choose between them
Product Innovation Sep 24, 2026

One model to dose them all: a unified model for aminoglycosides across the lifespan
Product Innovation Sep 3, 2026

Should I use CKD-EPI eGFR instead of Cockcroft-Gault CrCL for model-informed precision dosing? A vancomycin case study
Thought Leadership Sep 3, 2026

New consensus guidance for beta-lactam dose individualization
Thought Leadership Jun 10, 2026

From Computational Models to Agentic Clinical AI
Thought Leadership May 28, 2026

One small nudge for vancomycin dosing, one easy win for AUC target attainment
Thought Leadership Mar 31, 2026

Benchmarking the Hartford Nomogram Against Model-Informed Precision Dosing for Aminoglycosides
Thought Leadership Mar 5, 2026

Is There a Role for Model-Informed Precision Dosing of Cefepime?
Thought Leadership Feb 24, 2026

Do I Really Need Just Four Samples? Busulfan and Limited Sampling Strategies
Thought Leadership Feb 10, 2026

From Chatbots to Bedside-Ready AI Systems
Thought Leadership Dec 11, 2025

Beyond the Hype: A Pragmatic Look at Machine Learning for Precision Dosing
Thought Leadership Sep 21, 2025

Model-Informed Precision Dosing for Conditioning Regimens: Busulfan, Fludarabine, ATG, and More
Product Innovation Sep 5, 2025

New Continuous Learning PK Model Outperforms Published PopPK Models for Gentamicin
Thought Leadership Sep 3, 2025

The Complexity of Antifungal Dosing: Why Precision Matters More Than Ever
Product Innovation Aug 8, 2025

Improving Vancomycin Dosing in Pediatric Subpopulations (Part II): Guiding Model Selection in Oncology Patients
Product Innovation Jul 30, 2025

Improving Vancomycin Dosing in Pediatric Subpopulations (Part I): Guiding Model Selection in CVICU Patients
Thought Leadership Jul 29, 2025

How InsightRX Verifies Pharmacokinetic Models in Nova for Precision Dosing Accuracy
Thought Leadership Jul 21, 2025

Pharmacokinetic Model Comparisons: How We Do It and Why it Matters
Product Innovation Jul 16, 2025

Elevating Precision Dosing for Hemodialysis Patients: A New Vancomycin CRRT Model
Thought Leadership Apr 24, 2025

Beyond Vancomycin: Why Linezolid & Daptomycin Call for Precision Dosing
Thought Leadership Feb 24, 2025

From Empiric to Precise: Transforming Tacrolimus Dosing and Monitoring with MIPD
Thought Leadership Dec 26, 2024

How are pharmacokinetic models selected for InsightRX Nova?
Thought Leadership Dec 3, 2024

NCA vs. MAP Bayesian estimation for dose adjustment of busulfan and other medications
Thought Leadership Nov 6, 2024

Heparin: the puppy who won’t sit still
Thought Leadership Oct 4, 2024

Understanding Model-Informed Precision Dosing (MIPD) and Bayesian Statistics in Pharmacy
Thought Leadership Sep 18, 2024

How well do AUC24 estimates and trough estimates correlate in vancomycin?
Thought Leadership Sep 18, 2024

Overcoming barriers to beta-lactam TDM through Bayesian model-informed precision dosing
Product Innovation Sep 11, 2024

Choosing the right model for your patient: An introduction to InsightRX Gemini
Thought Leadership Sep 10, 2024

Streamlining Patient Care with EHR Integration
Thought Leadership Jun 28, 2024

AUC Monitoring for Vancomycin: Comparing Estimation Methods
Thought Leadership Jun 13, 2024

Recognizing the value of therapeutic drug monitoring for beta-lactam antibiotics
Product Innovation May 28, 2024

Apollo: Enhancing Data-Driven Insights and Real-Time Recommendations
Thought Leadership Feb 27, 2024

Artificial Intelligence Drives Industry Response to Project Optimus
Thought Leadership Jan 12, 2024

Improving Hospital Workflows by Integrating a Precision Dosing Platform with EHRs
Thought Leadership Oct 12, 2023

Using hybrid PKPD/ML models to accurately predict risk of neutropenia
Thought Leadership Aug 15, 2023

Simulation Demonstrates Potential Effectiveness of Model-Informed Precision Dosing for Heparin
Thought Leadership Jul 3, 2023

How Clinical Decision Support for Precision Dosing Can Enhance Healthcare Equity and Inclusion
Thought Leadership Feb 28, 2023

What Does 2023 Hold for Biopharma? Part 5: Technological Advances
Thought Leadership Jan 3, 2023

The 2023 PharmaVoice Crystal Ball: Peering into the future of life sciences
Thought Leadership Dec 16, 2022

What to Expect from AI-Enabled Drug Discovery in 2023
Thought Leadership Sep 7, 2022

The Evolution of Therapeutic Drug Monitoring for Tacrolimus
Thought Leadership Jul 13, 2022

Understanding Project Optimus
Thought Leadership Apr 6, 2022

Understanding FDA’s Perspective On Precision Dosing
Product Innovation Apr 5, 2022

Roadmap Preview: Biomarker-Guided And Pharmacogenomic-Informed Dosing
Product Innovation Mar 25, 2022

Roadmap Preview: Bringing Precision Dosing To New Therapeutic Areas
Product Innovation Mar 11, 2022

2021 Year in Review and Recent Product Enhancements
Thought Leadership Jan 11, 2022

The Role Of The Democratized Research Network In Optimizing Precision Dosing
Thought Leadership Jul 18, 2018

The Right Dose: How Pharmacy Researchers Are Making Medicine More Precise
Thought Leadership Mar 31, 2018

Investing In The Future Of Healthcare With OSF Healthcare

Maximize therapeutic success
with precision medicine.

Contact Us